Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 21, 2021 - Issue 5
Submit an article Journal homepage
146
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Exploring the consistency of the SF-6Dv2 in a breast cancer population

Hosein Ameria Health Policy and Management Research Center, Department of Health Services Management, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, IranView further author information
,
Hossein Safarib Health Promotion Research Centre, Iran University of Medical Sciences, Tehran, IranView further author information
&
Thomas Poderc Department of Management, Evaluation and Health Policy, School of Public Health, University of Montreal, Montreal, QC, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7017-096XView further author information
ORCID Icon
Pages 1017-1024 | Received 22 Aug 2020, Accepted 23 Oct 2020, Published online: 01 Dec 2020

References

  • Yousefi M, Safari H, Sari AA, et al. Assessing the performance of direct and indirect utility eliciting methods in patients with colorectal cancer: EQ-5D-5L versus C-TTO. Health Serv Outcomes Res Methodol. 2019;19(4):259–270.
  • EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
  • Brazier J, Usherwood T, Harper R, et al. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol. 1998;51(11):1115–1128.
  • Torrance GW, Furlong W, Feeny D, et al. Multi-attribute preference functions. Pharmacoeconomics. 1995;7(6):503–520.
  • Kaplan RM, Anderson JP. A general health policy model: update and applications. Health Serv Res. 1988;23(2):203.
  • Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001;33(5):328–336.
  • Brazier JE, Mulhern BJ, Bjorner JB, et al., Developing a new version of the SF-6D health state classification system from the SF-36v2: SF-6Dv2. Med Care. 2020;58(6):557–565. .
  • Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–292.
  • Mulhern BJ, Bansback N, Norman R, et al. Valuing the SF-6Dv2 classification system in the United Kingdom using a discrete-choice experiment with duration. Med Care. 2020;58(6):566–573.
  • Poder TG, Fauteux V, He J, et al. Consistency between three different ways of administering the short form 6 dimension version 2. Value Health. 2019;22(7):837–842. .
  • Ferreira LN, Ferreira PL, Pereira LN, et al. Exploring the consistency of the SF-6D. Value Health. 2013;16(6):1023–1031. .
  • Weinstein MC, Torrance G, McGuire A. QALYs: the basics. Value Health. 2009;12:S5–S9.
  • Crawford B, Brazier J, Strand V, et al. Treatment with leflunomide improves the utility of patients with active rheumatoid arthritis: an application of the sf-6d. Value Health. 2001;4(2):70–71.
  • Ferreira LN, Ferreira PL, Pereira LN, et al. An application of the SF-6D to create heath values in Portuguese working age adults. J Med Econ. 2008;11(2):215–233.
  • Blumenauer B, Cranney A, Clinch J, et al. Quality of life in patients with rheumatoid arthritis. Pharmacoeconomics. 2003;21(13):927–940.
  • Kopec JA, Willison KD. A comparative review of four preference-weighted measures of health-related quality of life. J Clin Epidemiol. 2003;56(4):317–325.
  • Kortt MA, Clarke PM. Estimating utility values for health states of overweight and obese individuals using the SF-36. Qual Life Res. 2005;14(10):2177–2185.
  • Nahvijou A, Safari H, Ameri H. Comparing the performance of the EQ-5D-5L with two versions of the SF-6Dv2 in patients with breast cancer. Health Serv Outcomes Res Methodol. 2020;20(2):183–94.
  • Nahvijou A, Safari H, Yousefi M, et al. Mapping the cancer-specific FACT-B onto the generic SF-6Dv2. Breast Cancer. 2020;1–7.
  • Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. John wiley & sons; 2013.
  • Harvill LM. Standard error of measurement: an NCME instructional module on. Educ Meas. 1991;10(2):33–41.
  • Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42.
  • Walters SJ, Brazier JE. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes. 2003;1(1):4.
  • Mukaka MM. A guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012;24(3):69–71.
  • Ameri H, Yousefi M, Yaseri M, et al. Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients. Expert Rev Pharmacoecon Outcomes Res. 2019;19(1):89–96.
  • Kiadaliri AA. A comparison of Iran and UK EQ-5D-3L value sets based on visual analogue scale. Int J Health Policy Manag. 2017;6(5):267.
  • Brazier J, Roberts J, Tsuchiya A, et al. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 2004;13(9):873–884.
  • Green C, Brazier J, Deverill M. Review of health state valuation techniques. Pharmacoeconomics. 2000;17(2):151–165.
  • Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes. 2007;5(1):70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.